With commercial insurance: J&J withMe Savings Program — as little as $5 per infusion, a yearly max that is not published on current terms (last published $20,000 a year). With Medicare: the Remicade card can’t be used. All 7 foundation funds we checked are closed as of October 12, 2026.
See what this patient owes after assistance →
9 assistance programs for Remicade patients · 1 open today
Manufacturer savings, charitable foundations, and patient assistance programs.
Select the patient's insurance and diagnosis to see which programs may apply.
Current status · Award amounts · Eligibility · Direct application links October 12, 2026
Checked September 28, 2026 · Source ↗
Checked September 28, 2026 · Source 1 ↗ · Source 2 ↗
Remicade’s card can’t be used with Medicare. These funds may help. They open and close with donations, so call before telling a Remicade patient no.
Checked September 28, 2026 · Source ↗
Remicade · Crohn's disease (adult) · Commercial insurance
Eligible patients may pay $5 per infusion
Example · Remicade · 400 mg · 40 units · commercial plan · deductible met · 20% coinsurance · allowed amounts at the Medicare reference rate
| Without assistance | With J&J withMe | |
|---|---|---|
| Drug responsibility | $238.85 | $5.00 |
| Administration (96413 + 96415) | $32.33 | $32.33 |
| Patient owes | $271.18 | $37.33 |
Estimated patient savings: $233.85
CareCost calculates the drug and administration lines using the patient’s payer rate and benefits; this example uses the Medicare rate as a reference.
Checked, and not available for this drug today
Free Johnson & Johnson Patient Assistance Program for eligible patients
Change the diagnosis to see only the programs that apply to your patient.
Remicade shares its class with Inflectra (Q5103, Pfizer), Renflexis (Q5104, Organon), Avsola (Q5121, Amgen), billed under their own codes with their own manufacturer programs. The programs above apply to Remicade only. If the payer requires Inflectra, Renflexis or Avsola instead of Remicade, use that maker’s program below.
Each Inflectra, Renflexis or Avsola card shows the date we last checked that program. Copay cards also say whether they pay the infusion or injection fee.
The three biosimilar programs differ most in their yearly caps, so check the Benefit line on each card before you quote one.
Pfizer enCompass Co-Pay Assistance Program (Inflectra)
Organon Co-pay Assistance Program (Renflexis)
Amgen SupportPlus Co-Pay Program (Avsola)
| Task | ✓ |
|---|---|
| Find programs for the diagnosis | ✓ |
| See whether each program is open | ✓ |
| See maximum award | ✓ |
| Review key eligibility requirements | ✓ |
| Open the official application | ✓ |
| Calculate cost before assistance | ✓ |
| Apply the program benefit | ✓ |
| Calculate what the patient still owes | ✓ |
Commercial insurance — Eligible commercially insured patients may qualify for the J&J withMe Savings Program. Eligible patients may pay $5 per infusion for the medication, subject to current program terms and limits. View current program ↑
Medicare — Manufacturer copay savings cannot be used when government insurance is paying for Remicade; the federal Anti-Kickback Statute is why, per HHS OIG guidance on copayment coupons. Diagnosis-specific charitable foundations may provide help with copays, coinsurance, deductibles or other qualifying costs when funding is available. View current Medicare funds ↑
Why fund status matters — Foundation funds can change between: OPEN Accepting applications now · WAITLIST Not enrolling immediately · CLOSED Not accepting new applications. Every CareCost program card shows the status and the date it was verified.
Why diagnosis matters — Foundation assistance is generally organized around the patient's diagnosis rather than the drug alone. Two patients receiving Remicade may therefore have completely different assistance options.
Yes. The current manufacturer savings program is the J&J withMe Savings Program. Eligible commercially insured patients may pay $5 per infusion for eligible medication costs, subject to program terms. Apply on J&J withMe ↗ Calculate cost with the program →
No. Patients using Medicare or other government-funded insurance to pay for Remicade are not eligible for the manufacturer's copay savings program. Independent charitable funds may still be available. Check current Medicare funds ↑
The applicable IBD funds above show their current verified status. Fund availability changes as foundations receive and exhaust funding. Check today's status ↑
Data current: programs verified Oct 12, 2026
J&J withMe Savings Program · Johnson & Johnson Patient Assistance Program · TotalAssist (Patient Advocate Foundation, merged with PAN Foundation in 2026) · HealthWell Foundation · Pfizer enCompass Co-Pay Assistance Program (Inflectra) · Organon Co-pay Assistance Program (Renflexis) · Amgen SupportPlus Co-Pay Program (Avsola). Every program links directly to its official source or application page.
Last program check: .
Reviewed September 10, 2026 by Erin Rose, CareCost Estimate founder. Methodology →
CareCost